CURRENT TECHNIQUES IN CELL AND MOLECULAR-BIOLOGY

被引:6
作者
DOWNEY, GP
WADDELL, TK
FUKUSHIMA, T
SUEAQUAN, A
机构
[1] Cell and Molecular Biology Laboratory, Division of Respiratory Diseases, the Department of Medicine, Ont.
基金
英国医学研究理事会;
关键词
D O I
10.1016/0883-9441(95)90004-7
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Recent advances in the field of molecular biology have revolutionized our understanding of the functioning of living organisms and facilitated the development of robust tools for both diagnosis and treatment of diseases. With particular reference to the field of critical care medicine, development of molecular biology techniques have aided in the following: (1) rapid and highly specific detection of pathogenic infectious agents (eg, Mycobacterium tuberculosis, Pneumocystis carinii, cytomegalovirus, Legionella); (2) development of assays for measurement of circulating cytokines such as tumor necrosis factor (TNF) and interleukin (IL)-1 that has helped our understanding of the pathogenesis of the sepsis syndrome; (3) administration of antibodies or soluble receptors to attempt to prevent untoward effects of cytokines such as TNF or IL-1; and (4) the administration of recombinant deoxyribonucleic acid (DNA) or proteins to patients in an attempt to alter the course of a disease such as antioxidant enzymes (superoxide dismutase), The rapidity of progress in this field has been staggering, which necessitates frequent updating of our knowledge for clinicians to put these molecular tools to their best use, This brief review attempts to explain the basic principles of commonly used techniques in molecular biology including recombinant DNA, polymerase chain reaction, DNA libraries, gene therapy, and protein biochemistry in a manner that is understandable to those without an in-depth knowledge of the field. Copyright (C) 1995 by W.B, Saunders Company
引用
收藏
页码:136 / 149
页数:14
相关论文
共 22 条
[1]  
Ausubel, Brent, Kingston, Et al., Current Protocols in Molecular Biology, (1994)
[2]  
Bronson, Smithies, Altering mice by homologous recombination using embryonic stem cells, J Biol Chem, 269, pp. 27155-271558, (1994)
[3]  
Canonico, Conary, Meyrick, Brigham, Aerosol and intravenous transfection of human alpha I-antitrypsin gene to lungs of rabbits, Am J Respir Cell Mot Biol, 10, pp. 24-29, (1994)
[4]  
Casey, Balk, Bone, Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome, Ann Intern Med, 119, pp. 771-778, (1993)
[5]  
Colledge, Cystic fibrosis gene therapy, Curr Opin Genet Dev, 4, pp. 466-471, (1994)
[6]  
Conary, Parker, Christman, Et al., Protection of rabbit lungs from endotoxin injury by in vivo hyperexpression of the prostaglandin G/H synthase gene, J Clin Invest, 93, pp. 1834-1840, (1994)
[7]  
Fasano, Cousart, Neal, McCall, Increased expression of the interleukin 1 receptor on blood neutrophils of humans with the sepsis syndrome, J Clin Invest, 88, pp. 1452-1459, (1991)
[8]  
Fisher, Marra, Palardy, Et al., Human bactericidal/permeability-increasing protein reduces mortality from endotoxin challange: A placebo-controlled study, Crit Care Med, 22, pp. 553-558, (1994)
[9]  
Grossman, Raper, Kozarsky, Et al., Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaernia, Nat Genet, 6, pp. 335-341, (1994)
[10]  
Hoffmann, Selected Treatment Strategies for Septic Shock Based on Proposed Mechanisms of Pathogenesis, Annals of Internal Medicine, 120, pp. 771-783, (1994)